1
|
Smyth MR, Teicher S, Wilde DJ. How Does Denial, Minimization, Justifying, and Blaming Operate in Intimate Partner Abuse Committed by Men: A Systematic Review of the Literature. Trauma Violence Abuse 2023:15248380231196108. [PMID: 37702188 DOI: 10.1177/15248380231196108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 09/14/2023]
Abstract
Intimate partner abuse (IPA) is widespread, and denial, minimization, justifying, and blaming (DMJB) are common among people who have committed IPA. Views on the function of DMJB in IPA are mixed, often based on the theoretical standpoint of the authors. This systematic review brings together the knowledge of how distorted accounts operate in IPA committed by men. A systematic review of primary research related to DMJB in heterosexual men who have committed to IPA was conducted. In all, 31 papers were found to meet the inclusion criteria (adult, male-to-female abuse, in western culture, peer reviewed and published in English) and were quality appraised. Data were extracted and analyzed using narrative synthesis. The findings indicate the way DMJB operates in this group is complex. It can represent facilitators of abusive behavior, a way to protect the individual's identity and self-esteem, and a tool men use instrumentally to achieve goals. Themes were present within and between studies highlighting the complex function of DMJB. A model representing the hypothesized intertwined function of DMJB for IPA is proposed. The limitations of the review are discussed and implications and recommendations for policy, practice, and future research are proposed.
Collapse
Affiliation(s)
- Madeline R Smyth
- Forensic Psychology Services, HMPPS in Wales, HMP Berwyn, Wrexham, UK
| | | | - David J Wilde
- Psychology Department, Nottingham Trent University, Nottingham, UK
| |
Collapse
|
2
|
Masterson AN, Muhoberac BB, Gopinadhan A, Wilde DJ, Deiss FT, John CC, Sardar R. Multiplexed and High-Throughput Label-Free Detection of RNA/Spike Protein/IgG/IgM Biomarkers of SARS-CoV-2 Infection Utilizing Nanoplasmonic Biosensors. Anal Chem 2021; 93:8754-8763. [PMID: 34125535 PMCID: PMC8230954 DOI: 10.1021/acs.analchem.0c05300] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Accepted: 06/02/2021] [Indexed: 12/24/2022]
Abstract
To tackle the COVID-19 outbreak, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an unmet need for highly accurate diagnostic tests at all stages of infection with rapid results and high specificity. Here, we present a label-free nanoplasmonic biosensor-based, multiplex screening test for COVID-19 that can quantitatively detect 10 different biomarkers (6 viral nucleic acid genes, 2 spike protein subunits, and 2 antibodies) with a limit of detection in the aM range, all within one biosensor platform. Our newly developed nanoplasmonic biosensors demonstrate high specificity, which is of the upmost importance to avoid false responses. As a proof of concept, we show that our detection approach has the potential to quantify both IgG and IgM antibodies directly from COVID-19-positive patient plasma samples in a single instrument run, demonstrating the high-throughput capability of our detection approach. Most importantly, our assay provides receiving operating characteristics, areas under the curve of 0.997 and 0.999 for IgG and IgM, respectively. The calculated p-value determined through the Mann-Whitney nonparametric test is <0.0001 for both antibodies when the test of COVID-19-positive patients (n = 80) is compared with that of healthy individuals (n = 72). Additionally, the screening test provides a calculated sensitivity (true positive rate) of 100% (80/80), a specificity (true negative rate) >96% (77/80), a positive predictive value of 98% at 5% prevalence, and a negative predictive value of 100% at 5% prevalence. We believe that our very sensitive, multiplex, high-throughput testing approach has potential applications in COVID-19 diagnostics, particularly in determining virus progression and infection severity for clinicians for an appropriate treatment, and will also prove to be a very effective diagnostic test when applied to diseases beyond the COVID-19 pandemic.
Collapse
Affiliation(s)
- Adrianna N. Masterson
- Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N Blackford Street, Indianapolis, Indiana 46202, United States
| | - Barry B. Muhoberac
- Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N Blackford Street, Indianapolis, Indiana 46202, United States
| | - Adnan Gopinadhan
- Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, 1044 W. Walnut St, Indianapolis, Indiana, 46205, United States
| | - David J. Wilde
- Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N Blackford Street, Indianapolis, Indiana 46202, United States
| | - Frédérique T. Deiss
- Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N Blackford Street, Indianapolis, Indiana 46202, United States
| | - Chandy C. John
- Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, 1044 W. Walnut St, Indianapolis, Indiana, 46205, United States
| | - Rajesh Sardar
- Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N Blackford Street, Indianapolis, Indiana 46202, United States
- Integrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, 723 W. Michigan Street, Indianapolis, Indiana 46202, United States
| |
Collapse
|
3
|
Caldon LJM, Collins KA, Wilde DJ, Ahmedzai SH, Noble TW, Stotter A, Sibbering DM, Holt S, Reed MWR. Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer. Br J Cancer 2011; 104:1551-7. [PMID: 21559024 PMCID: PMC3101915 DOI: 10.1038/bjc.2011.141] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND Hospital mastectomy rates vary. This study explores the relationship between mastectomy rates and breast cancer patients' consultation and decision-making experiences with specialist clinicians. METHODS Qualitative semi-structured interviews were conducted with 65 patients from three purposively selected breast units from a single UK region. Patients provided with a choice of breast cancer surgery (breast conservation therapy (BCT) or mastectomy) were purposively recruited from high, medium and low case-mix-adjusted mastectomy rate units. RESULTS Low mastectomy rate unit patients' consultation and decision-making experiences were markedly different to those of the medium and high mastectomy rate breast units. Treatment variation was associated with patients' perception of the most reassuring and least disruptive treatment; the content and style of information provision (equipoise or directed); level of patient participation in decision making; the time and process of decision making and patient autonomy in decision making. The provision of more comprehensive less directive information and greater autonomy, time and support of independent decision making were associated with a lower uptake of BCT. CONCLUSION Variation in hospital mastectomy rates was associated with differences in the consultation and decision-making experiences of breast cancer patients. Higher mastectomy rates were associated with the facilitation of more informed autonomous patient decision making.
Collapse
Affiliation(s)
- L J M Caldon
- Department of Oncology, University of Sheffield, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, UK.
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Wilde DJ. The practitioner as recruiter. J Am Med Rec Assoc 1991; 62:51. [PMID: 10109218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
The following article by Donna J. Wilde, MPA, RRA, is the first in a series of brief articles aimed at focusing members' attention on the vital importance of recruiting students to medical record programs. If our profession is to grow in numbers and in high level performers, we must begin attracting students to the challenging world of healthcare information management. Wilde discusses the topic from the educator's viewpoint.
Collapse
Affiliation(s)
- D J Wilde
- Shoreline Community College Medical Record Technology Program, Seattle, WA
| |
Collapse
|